| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | ETRASIMOD | 4 |
| 2 | INFLIXIMAB | 4 |
| 3 | METHOTREXATE | 4 |
| 4 | METHOTREXATE SODIUM | 4 |
| 5 | PREDNISONE | 4 |
| 6 | USTEKINUMAB | 4 |
| 7 | VEDOLIZUMAB | 4 |
| 8 | ADALIMUMAB-ADAZ | 2 |
| 9 | ELAPEGADEMASE-LVLR | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELAPEGADEMASE-LVLR | 1 | 0.0033 |
| 1 | ETRASIMOD | 4 | 0.0024 |
| 2 | VEDOLIZUMAB | 4 | 0.0000 |
| 3 | USTEKINUMAB | 4 | 0.0000 |
| 4 | ADALIMUMAB-ADAZ | 2 | 0.0000 |
| 5 | INFLIXIMAB | 4 | 0.0000 |
| 6 | METHOTREXATE SODIUM | 4 | 0.0000 |
| 7 | PREDNISONE | 4 | 0.0000 |
| 8 | ADALIMUMAB | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| 1 | Corticosteroid [EPC] | 4 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 4 |
| 3 | Integrin Receptor Antagonist [EPC] | 4 |
| 4 | Interleukin-12 Antagonist [EPC] | 4 |
| 5 | Interleukin-23 Antagonist [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 4 | 0.0000 |
| 1 | Interleukin-12 Antagonist [EPC] | 4 | 0.0000 |
| 2 | Interleukin-23 Antagonist [EPC] | 4 | 0.0000 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 6 | 0.0000 |
| 5 | Corticosteroid [EPC] | 4 | 0.0000 |